Seres Therapeutics, Inc.MCRBNASDAQ
Loading
Direct costs attributable to producing goods sold
5Y CAGR
-46.1%/yr
Long-term compound
Percentile
P62
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $4.13M | +17.0% |
| 2024 | $3.53M | - |
| 2023 | $0.00 | - |
| 2022 | $0.00 | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $90.57M | - |
| 2019 | $0.00 | -100.0% |
| 2018 | $95.95M | +7.3% |
| 2017 | $89.45M | +9.1% |
| 2016 | $81.99M | - |